Belen Borrego works at the Animal Health Research Centre, INIA/CSIC. Her work is focused on development and improvment of novel strategies to control viral infectious diseases relevant for Animal Health. Her most recent publication is 'Insights on the Use of the Extremely Attenuated Variant of Rift Valley Fever Virus (RVFV) 40fp8 as a Safer Live-Attenuated Vaccine", a work presented at the last Vaccine Congress in Glasgow, 2023.